![]() “COVID-19 is placing a spotlight on the importance of fast, comprehensive molecular testing,” said Scott Mendel, chief executive of GenMark, in a statement. The company manufactures the panels at facilities in Carlsbad, where it employs about 600 workers. GenMark, BioFire and Cepheid are the most active in the market now, with Luminex also working on a panel test.ĭemand for GenMark’s test so far has been strong, said O’Brien. But quick, highly sensitive test for hospitals, that is still an area that is underserved.” “Well, there is for certain kinds of tests. “People say, Oh, there is tons of testing available,” said O’Brien. That means doctors must order a series of standalone tests for COVID or the flu or other ailments to make a diagnosis for people with symptoms. Syndromic panel tests, on the other hand, are not as widely available, said O’Brien. College and professional athletes also use rapid antigen tests to COVID screening before practice and games. The PCR test, which hunts down genetic material from the viruses, is considered more accurate than antigen tests, which are inexpensive and provide quick, repeatable results in as little as 15 minutes.Īntigen tests have become a more widely available tool for screening people without symptoms for COVID, particularly those working in nursing homes or other high-risk settings. Now it has combined that into a more wide-ranging test for multiple respiratory ailments. In March, GenMark received FDA Emergency Use Approval for a stand-alone COVID-19 test. Syndromic testing has been around for about five years or so.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |